That disease is Alzheimer’s disease. Let’s begin with some definitions. Alzheimer’s disease is a degenerative brain disease ...

One in three people born in the UK today will develop dementia in their lifetime, with most of these cases caused by ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Health conditions associated with Alzheimer’s can arise well before the diagnosis of this devastating disease.

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...

A groundbreaking study by researchers from the University of Delaware College of Health Sciences and the National Institute ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

As the disease progresses to moderate dementia, damage in areas of the brain that control language, reasoning, conscious thought, and sensory processing lead to more severe symptoms.